public health, developmental biology, genetics & genomics
Are the Kids Alright?
Are the Kids Alright?
Bob Grant | Mar 1, 2012
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
Speaking of Science
The Scientist Staff | Mar 1, 2012
March 2012's selection of notable quotes
Capsule Reviews
Bob Grant | Mar 1, 2012
The Wandering Gene and the Indian Princess, The Forever Fix, Connectome, and DNA USA
The Specter of Denialism
Nicoli Nattrass | Mar 1, 2012
Conspiracy theories surrounding the global HIV/AIDS epidemic have cost thousands of lives. But science is fighting back.
Child-Proofing Drugs
Edyta Zielinska | Mar 1, 2012
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Model Citizen
Karen Hopkin | Mar 1, 2012
With an eye to understanding animal regeneration, Alejandro Sánchez Alvarado has turned a freshwater planarian into a model system to watch.
Combing the Cancer Genome
Carina Storrs | Mar 1, 2012
A guided tour through the main online resources for analyzing cancer genomics data
One Year On
Nick Beresford and Jordi Vives i Batlle | Mar 1, 2012
Some thoughts about the ecological fallout from Fukushima
New Mice on the Block
Megan Scudellari | Feb 29, 2012
After 10 years in development, a novel mouse population proves its mettle in complex trait research.
Elsevier Abandons Anti-Open Access Bill
Bob Grant | Feb 28, 2012
The publishing giant withdraws its support of the Research Works Act, which would eliminate open-access requirements on federally funded work.